Saltar al contenido
Global sound
DNA Today: A Genetics Podcast

DNA Today: A Genetics Podcast

#405 Why Insurance Denies Genetic Testing, and How to Navigate Coverage

· 35 min · Episodio 405

Notas del episodio

Genetic testing can change the course of a patient’s care, but accessing the right test is not always straightforward.
Behind the scenes, insurance coverage decisions, documentation requirements, prior authorization, denials, appeals, and cost concerns can all influence whether a patient receives timely answers.
In this episode of DNA Today, we launch a new special series sponsored by Revvity in this episode exploring the health economics of genetic testing and the real-world systems that shape access to genomic medicine.
Host Kira Dineen is joined by Dr. Madhuri Hegde, Senior Vice President and Chief Scientific Officer at Revvity, and Mackenzie Mosera Derby, a pediatric genetic counselor at UW Health. Together, they examine genetic testing access from both the diagnostic laboratory and clinical perspectives exploring why insurance coverage remains so inconsistent, what goes into a prior authorization, why genetic tests are commonly denied, and how clinicians can approach appeals and peer-to-peer reviews.
In This Episode, We Discuss

The transition from stacked laboratory procedure codes to codes for genes, panels, exomes, and genomes
How and why insurance coverage varies among payers and individual health plans
Coverage differences across hereditary cancer testing, exome sequencing, genome sequencing, reproductive testing, and population screening
How rapid and ultra-rapid genome sequencing may be covered differently from standard genome sequencing
The limited coverage available for preventive and population-based genomic testing
The coordination required among patients, clinicians, laboratories, and insurance companies
Why laboratories offering tests with similar names may differ in technology, interpretation, turnaround time, and clinical support
What documentation is typically required for a genetic testing prior authorization
How clinicians demonstrate medical necessity and clinical utility
Why professional guidelines and peer-reviewed literature can strengthen an authorization request
The role laboratories play in benefits investigations, billing assistance, financial support, and prior authorization
Why laboratories may perform testing without knowing whether they will ultimately be reimbursed
Common reasons insurance companies deny genetic testing
Why “this test will not change clinical management” can be an overly narrow interpretation of genetic testing’s value
How genetic results may inform surveillance, reproductive decisions, recurrence risks, family members, research eligibility, and patient support
The role of hospital test utilization committees
Why genetic counselors and geneticists should be represented on utilization review teams
How letters of medical necessity (LOMN) and peer-to-peer reviews may support an appeal
Why genetic counselors may be prevented from conducting peer-to-peer reviews, even when they were the ordering provider
The time clinicians spend educating insurance representatives about genetics
Why payer…

Web: dnatodaypodcast.podbean.com

En directo, última hora: 6.712 canciones en 2.366 emisoras de 116 países

Descubre el mundo a través de la radio

Más formas de descubrir (7)

¿Has oído algo bueno? Guárdalo o ábrelo directamente en Spotify.

★ Artista de la semana El que más sube en la radio esta semana
¿Tu canción aquí? Desde € 9 por semana →
Radio WUEVSeguir escuchando